目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of This Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Highlights of the Market for Cell and Gene Therapy
Table Summary : Global Market for Cell and Gene Therapy, by Therapy Type, Through 2026
Figure Summary : Global Market for Cell and Gene Therapy, by Therapy Type, 2019-2026

Chapter- 3: Cell and Gene Therapy: Background and Technology
Cell and Gene Therapy Overview

Chapter- 4: Market Dynamics
Market Dynamics

Chapter- 5: Market Breakdown by Therapy Type
Global Market for Cell and Gene Therapy
Cell Therapy
Gene-Modified Cell Therapy
Gene Therapy
Global Market for Gene Modified Cell Therapy and Gene Therapy by Vector Type

Chapter- 6: Market Breakdown by Product
Global Market for Cell and Gene Therapy by Product

Chapter- 7: Market Breakdown by Application
Global Market for CGTs by Application
Rare Diseases
Oncology
Hematology
Ophthalmology
Neurology
Other Therapeutic Areas

Chapter- 8: Market Breakdown by Region
Global Market for Cell and Gene Therapy by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 9: Impact of the COVID-19 Pandemic
Introduction
Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology

Chapter- 10: Pipeline Analysis
Pipeline Analysis

Chapter- 11: Competitive Landscape
Competitive Landscape: Overview

Chapter- 12: Company Profiles
AMGEN INC.
BLUEBIRD BIO INC.
BRISTOL-MYERS SQUIBB CO.
DENDREON PHARMACEUTICALS LLC
GILEAD SCIENCES INC.
NOVARTIS INTERNATIONAL AG
ORCHARD THERAPEUTICS PLC.
PHARMICELL CO. LTD.
SIBIONO GENETECH CO. LTD.
VERICEL CORP.

Chapter- 13: Appendix: List of Acronyms
Table 44 : Acronyms Used in This Report